의료용 접착제 시장 : 기술별, 수지 유형별, 용도별, 지역별 - 세계 예측(-2031년)

The medical adhesives market is projected to grow from USD 11.38 billion in 2026 to USD 14.90 billion by 2031, at a CAGR of 5.5% during the forecast period.

The medical adhesives market is growing as healthcare facilities need stronger, biocompatible, and durable bonding materials. The rising number of surgical procedures, together with the growing acceptance of minimally invasive procedures, is driving hospitals to use medical adhesives for wound closure, tissue sealing, and hemostasis.

The increasing use of wearable medical devices, together with transdermal drug delivery systems, creates a higher demand for skin-compatible flexible adhesives that can be worn for extended periods. The combination of growing elderly populations and rising chronic wound cases drives higher demand for advanced wound care products, including adhesive dressings and sealants. The medical device manufacturing industry requires high-performance adhesives, which are essential for assembling and fixing devices. The rapid development of healthcare facilities in emerging markets opens new business opportunities. Product performance and market growth receive boosts from ongoing supply-side product advances, the development of silicone and acrylic adhesive systems, and increased dedication to meeting regulatory requirements and using sustainable materials.

Based on technology, the medical adhesives market is divided into three segments: water-based adhesives, solvent-based adhesives, and solid & hot melt adhesives. Water-based adhesives lead the market because they provide excellent biocompatibility and low toxicity and produce minimal volatile organic compound emissions, making them suitable for skin-contact and wound care applications. Medical tapes, dressings, and wearable devices use these adhesives to ensure patient safety and comfort. The bonding strength and durability of solvent-based adhesives remain strong, yet their market growth continues to decline because of environmental regulations that restrict solvent emissions. Solid and hot-melt adhesives are now seeing increased use in medical device assembly and hygiene applications because they provide fast curing times, simple processing, and effective adhesion to multiple materials. The water-based adhesive market is the dominant force because rising regulations mandate environmentally friendly products without toxic components and because healthcare demands require both safe and effective solutions.

Based on resin type, the medical adhesives market is divided into three categories: fibrin, collagen, and other medical adhesive products. Fibrin-based adhesives maintain the largest market share because they provide better biocompatibility and function as natural components of the body healing process. Fibrin adhesives, which derive from human or animal plasma components, create a complete blood coagulation system that surgeons use for hemostasis, tissue sealing, and wound closure. The medical community uses these products because they help patients heal faster while controlling blood loss and reducing the risk of adverse health effects during cardiovascular, orthopedic, and general surgical operations. Collagen-based adhesives are becoming more popular because they provide excellent tissue compatibility, which helps cells grow, especially in wound care and regenerative medicine. Specialized applications that need strong bonding and controlled degradation use synthetic adhesives, which include cyanoacrylates and polyethylene glycol (PEG)-based formulations as their preferred resin types. Fibrin adhesives represent the preferred choice because they provide safe usage, effective results in emergency medical situations, and growing demand for biologically based medical solutions in contemporary healthcare.

Based on region, Asia Pacific represents the fastest expanding market for medical adhesives because healthcare facilities in China, India, and Southeast Asia experience rapid development while their population numbers and healthcare spending patterns continue to rise. The increasing number of chronic disease cases, together with the expanding elderly population, creates a greater need for advanced wound care solutions and surgical treatments, which results in higher consumption of medical adhesives. The region experiences strong growth in medical device manufacturing due to lower costs, supportive government regulations, and rising foreign investment. Product usage increases as hospitals, clinics, and ambulatory care centers continue to expand their operations. Rising knowledge of minimally invasive surgical methods, together with modern treatment solutions, creates a market need for superior adhesive products. The medical adhesives market in Asia Pacific experiences rapid growth because local manufacturing resources and foreign companies establishing production centers in the area enhance supply distribution and operational efficiency.

Major players operating in the market include Solventum (US), Henkel AG & Co. KGaA (Germany), H.B. Fuller Company (US), Scapa Healthcare (US), Johnson & Johnson (US), Permabond (UK), Chemence Medical, Inc (US), Artivion, Inc (US), Dymax (Ireland), and Bostik (France). These companies have dependable manufacturing facilities across the Asia Pacific region, as well as robust distribution networks. They have a well-established portfolio that includes reliable goods and services, a strong market presence, and effective business plans. These businesses also hold a sizable portion of the market, offer a broader range of products with more applications, and use cases spanning more geographic regions.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNITS CONSIDERED
• 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS IN MEDICAL ADHESIVES MARKET
• 2.4 HIGH GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL ADHESIVES MARKET
• 3.2 MEDICAL ADHESIVES MARKET, BY TECHNOLOGY AND REGION
• 3.3 MEDICAL ADHESIVES MARKET, BY RESIN TYPE
• 3.4 MEDICAL ADHESIVES MARKET, BY APPLICATION
• 3.5 MEDICAL ADHESIVES MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising demand for minimally invasive surgeries
    • 4.2.1.2 Growth in wearable and portable medical devices
    • 4.2.1.3 Advancements in biocompatible and light-curable technologies
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Stringent regulatory requirement
    • 4.2.2.2 Risk of skin irritation and biocompatibility issues
    • 4.2.2.3 Availability of alternative wound closure methods
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Growth in home healthcare and remote diagnostics
    • 4.2.3.2 Innovations in advanced adhesive technologies
    • 4.2.3.3 Integration with smart and minimally invasive surgical solutions
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Compatibility with new medical devices
    • 4.2.4.2 Technological complexity in product development
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN MEDICAL ADHESIVES MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
  • 4.5.1 KEY MOVES AND STRATEGIC FOCUS
• 4.6 PORTER'S FIVE FORCES ANALYSIS
  • 4.6.1 THREAT OF NEW ENTRANTS
  • 4.6.2 THREAT OF SUBSTITUTES
  • 4.6.3 BARGAINING POWER OF SUPPLIERS
  • 4.6.4 BARGAINING POWER OF BUYERS
  • 4.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 4.7 VALUE CHAIN ANALYSIS
• 4.8 ECOSYSTEM
• 4.9 PRICING ANALYSIS
  • 4.9.1 AVERAGE SELLING PRICE, BY REGION
  • 4.9.2 AVERAGE SELLING PRICE, BY TECHNOLOGY
  • 4.9.3 AVERAGE SELLING PRICE, BY APPLICATION
• 4.10 MACROECONOMIC INDICATORS
  • 4.10.1 GLOBAL GDP TRENDS
• 4.11 IMPACT OF 2025 US TARIFFS ON MEDICAL ADHESIVES MARKET
  • 4.11.1 INTRODUCTION
  • 4.11.2 KEY TARIFF RATES
  • 4.11.3 PRICE IMPACT ANALYSIS
  • 4.11.4 IMPACT ON COUNTRIES/REGIONS
    • 4.11.4.1 US
    • 4.11.4.2 Europe
    • 4.11.4.3 Asia Pacific
  • 4.11.5 IMPACT ON END-USE INDUSTRIES
• 4.12 TRADE ANALYSIS
  • 4.12.1 IMPORT SCENARIO (HS CODE 300590)
  • 4.12.2 EXPORT SCENARIO (HS CODE 300590)
• 4.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 4.14 INVESTMENT AND FUNDING SCENARIO
• 4.15 CASE STUDIES
  • 4.15.1 BIOCOMPATIBLE EPOXY ENCAPSULANTS IN MEDICAL DEVICE MANUFACTURING
  • 4.15.2 SILICONE ADHESIVES FOR LONG-WEAR WEARABLE DEVICES
  • 4.15.3 CYANOACRYLATE ADHESIVES FOR SURGICAL WOUND CLOSURE
• 4.16 KEY CONFERENCES & EVENTS

5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 5.1 TECHNOLOGY ANALYSIS
  • 5.1.1 KEY TECHNOLOGIES
    • 5.1.1.1 Solids hot melt adhesives
    • 5.1.1.2 UV curable adhesives
  • 5.1.2 COMPLEMENTARY TECHNOLOGIES
    • 5.1.2.1 Water-based (emulsion) adhesives
    • 5.1.2.2 Silicone-based adhesives
  • 5.1.3 ADJACENT TECHNOLOGIES
    • 5.1.3.1 Medical sealants & hemostats
• 5.2 TECHNOLOGY/PRODUCT ROADMAP
  • 5.2.1 SHORT TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 5.2.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
  • 5.2.3 LONG TERM (2030-2030+) | MASS COMMERCIALIZATION & DISRUPTION
• 5.3 PATENT ANALYSIS
  • 5.3.1 LEGAL STATUS OF PATENTS
  • 5.3.2 JURISDICTION ANALYSIS
• 5.4 FUTURE APPLICATIONS
  • 5.4.1 WEARABLE & REMOTE MONITORING DEVICES
  • 5.4.2 MINIMALLY INVASIVE & ROBOTIC SURGERIES
  • 5.4.3 IMPLANTABLE MEDICAL DEVICES
  • 5.4.4 ADVANCED WOUND CARE & REGENERATIVE MEDICINE
  • 5.4.5 TRANSDERMAL DRUG DELIVERY SYSTEMS
• 5.5 IMPACT OF AI/GEN AI ON MEDICAL ADHESIVES MARKET
  • 5.5.1 TOP USE CASES AND MARKET POTENTIAL
  • 5.5.2 BEST PRACTICES IN MEDICAL ADHESIVES PROCESSING
  • 5.5.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL ADHESIVES MARKET
  • 5.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 5.5.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL ADHESIVES MARKET

6 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

• 6.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.1.2 INDUSTRY STANDARDS
• 6.2 IMPACT OF REGULATORY POLICIES AND SUSTAINABILITY INITIATIVES
• 6.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 7.1 INTRODUCTION
• 7.2 DECISION-MAKING PROCESS
• 7.3 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 7.3.2 BUYING CRITERIA
• 7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 7.5 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
• 7.6 MARKET PROFITABILITY
  • 7.6.1 REVENUE POTENTIAL
  • 7.6.2 COST DYNAMICS
  • 7.6.3 MARGIN OPPORTUNITIES IN KEY END-USE INDUSTRIES

8 MEDICAL ADHESIVES MARKET, BY RESIN TYPE

• 8.1 INTRODUCTION
• 8.2 NATURAL RESIN
  • 8.2.1 GROWING PREFERENCE FOR BIOCOMPATIBLE AND BIO-BASED SOLUTIONS DRIVING ADOPTION
  • 8.2.2 FIBRIN
    • 8.2.2.1 Rising surgical procedures boosting adoption of fibrin-based medical adhesives
  • 8.2.3 COLLAGEN
    • 8.2.3.1 Expanding advanced wound care applications driving demand
  • 8.2.4 OTHER NATURAL RESINS
• 8.3 SYNTHETIC & SEMI-SYNTHETIC RESIN
  • 8.3.1 RISING DEMAND FOR HIGH-PERFORMANCE AND DURABLE BONDING SOLUTIONS DRIVING MARKET GROWTH
  • 8.3.2 ACRYLIC
    • 8.3.2.1 Growing adoption of wearable medical devices driving demand
  • 8.3.3 SILICONE
    • 8.3.3.1 Increasing demand for gentle, skin-friendly adhesion driving adoption
  • 8.3.4 CYANOACRYLATE
    • 8.3.4.1 Rising preference for sutureless wound closure to support market growth
  • 8.3.5 EPOXY
    • 8.3.5.1 Demand for high-strength bonding in medical device assembly to drive growth
  • 8.3.6 POLYURETHANE
    • 8.3.6.1 Need for flexible and durable medical materials fueling demand
  • 8.3.7 OTHER SYNTHETIC & SEMI-SYNTHETIC RESINS

9 MEDICAL ADHESIVES MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
• 9.2 WATER-BASED
  • 9.2.1 RISING DEMAND FOR BIOCOMPATIBLE AND SKIN-FRIENDLY SOLUTIONS DRIVING ADOPTION
• 9.3 SOLVENT-BASED
  • 9.3.1 HIGH BOND STRENGTH AND DURABILITY DRIVING DEMAND FOR SOLVENT-BASED MEDICAL ADHESIVES
• 9.4 SOLID & HOT MELT-BASED
  • 9.4.1 FAST PROCESSING AND SOLVENT-FREE FORMULATION DRIVING ADOPTION OF HOT MELT MEDICAL ADHESIVES

10 MEDICAL ADHESIVES MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 DENTAL
  • 10.2.1 RISING DEMAND FOR COSMETIC AND RESTORATIVE DENTISTRY DRIVING MARKET GROWTH
• 10.3 SURGERY
  • 10.3.1 GROWING SHIFT TOWARD MINIMALLY INVASIVE PROCEDURES DRIVING ADOPTION
  • 10.3.2 INTERNAL
    • 10.3.2.1 Increasing complex surgical procedures driving demand for internal medical adhesives
  • 10.3.3 EXTERNAL
    • 10.3.3.1 Rising preference for sutureless skin closure driving external adhesives demand
• 10.4 MEDICAL DEVICE & EQUIPMENT
  • 10.4.1 RAPID GROWTH OF WEARABLE AND MINIATURIZED DEVICES DRIVING DEMAND
• 10.5 OTHER APPLICATIONS

11 MEDICAL ADHESIVES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 Rising surgical volumes and advanced healthcare infrastructure driving demand
  • 11.2.2 CANADA
    • 11.2.2.1 Growing surgical procedures and aging population fueling demand
  • 11.2.3 MEXICO
    • 11.2.3.1 Expanding medical device manufacturing and healthcare infrastructure driving market growth
• 11.3 ASIA PACIFIC
  • 11.3.1 CHINA
    • 11.3.1.1 Massive healthcare expansion and government support driving demand
  • 11.3.2 INDIA
    • 11.3.2.1 Expanding healthcare coverage and rising surgical volumes fueling market growth
  • 11.3.3 JAPAN
    • 11.3.3.1 Rapidly aging population driving demand for advanced medical adhesives
  • 11.3.4 SOUTH KOREA
    • 11.3.4.1 Presence of advanced medical device industry driving medical adhesives demand
  • 11.3.5 REST OF ASIA PACIFIC
• 11.4 EUROPE
  • 11.4.1 GERMANY
    • 11.4.1.1 Strong healthcare infrastructure and high surgical volumes driving demand
  • 11.4.2 FRANCE
    • 11.4.2.1 Advanced healthcare systems and rising surgical procedures fueling market growth
  • 11.4.3 UK
    • 11.4.3.1 E-commerce sales to drive market expansion
  • 11.4.4 ITALY
    • 11.4.4.1 Rapidly aging population fueling demand for advanced wound care and surgical adhesives
  • 11.4.5 SPAIN
    • 11.4.5.1 Growing aging population and chronic disease burden driving demand
  • 11.4.6 REST OF EUROPE
• 11.5 MIDDLE EAST & AFRICA
  • 11.5.1 GCC COUNTRIES
    • 11.5.1.1 Saudi Arabia
      • 11.5.1.1.1 Vision 2030 healthcare investments accelerating market growth
    • 11.5.1.2 Rest of GCC
  • 11.5.2 SOUTH AFRICA
    • 11.5.2.1 Rising chronic disease burden and healthcare expansion supporting market growth
  • 11.5.3 REST OF MIDDLE EAST & AFRICA
• 11.6 SOUTH AMERICA
  • 11.6.1 BRAZIL
    • 11.6.1.1 Expanding public healthcare system driving medical adhesives demand
  • 11.6.2 ARGENTINA
    • 11.6.2.1 Rising chronic disease burden accelerating demand
  • 11.6.3 REST OF SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
• 12.3 REVENUE ANALYSIS
• 12.4 MARKET SHARE ANALYSIS, 2025
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/PRODUCT COMPARISON ANALYSIS
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.7.5.1 Overall company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Technology footprint
    • 12.7.5.4 Resin type footprint
    • 12.7.5.5 Application footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHERS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 SOLVENTUM (3M)
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches
      • 13.1.1.3.2 Deals
      • 13.1.1.3.3 Others
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 HENKEL AG & CO, KGAA
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 H.B. FULLER COMPANY
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 SCAPA HEALTHCARE
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 JOHNSON & JOHNSON (MEDTECH COMPANY)
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Key strengths
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses and competitive threats
  • 13.1.6 PERMABOND
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 MnM view
  • 13.1.7 B. BRAUN SE
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 MnM view
  • 13.1.8 CHEMENCE MEDICAL, INC.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Others
    • 13.1.8.4 MnM view
  • 13.1.9 ARTIVION, INC.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 MnM view
  • 13.1.10 DYMAX
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 MnM view
  • 13.1.11 BOSTIK
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
    • 13.1.11.4 MnM view
• 13.2 OTHER PLAYERS
  • 13.2.1 MEDTRONIC
  • 13.2.2 DENTSPLY SIRONA
  • 13.2.3 MASTERBOND INC.
  • 13.2.4 ASHLAND
  • 13.2.5 ADVANCED MEDICAL SOLUTIONS GROUP PLC
  • 13.2.6 HOENLE AG
  • 13.2.7 BECTON, DICKINSON AND COMPANY (BD)
  • 13.2.8 VIVOSTAT A/S
  • 13.2.9 OCULAR THERAPEUTIX, INC.
  • 13.2.10 GLAXOSMITHKLINE PLC
  • 13.2.11 NITTO DENKO CORPORATION
  • 13.2.12 BAXTER INTERNATIONAL
  • 13.2.13 CARTELL CHEMICAL CO., LTD.
  • 13.2.14 BIOSEAL INC.

14 RESEARCH METHODOLOGY

• 14.1 RESEARCH DATA
  • 14.1.1 SECONDARY DATA
    • 14.1.1.1 List of key secondary sources
    • 14.1.1.2 Key data from secondary sources
  • 14.1.2 PRIMARY DATA
    • 14.1.2.1 Key data from primary sources
    • 14.1.2.2 List of primary interview participants-demand and supply side
    • 14.1.2.3 Key industry insights
    • 14.1.2.4 Breakdown of interviews with experts
• 14.2 MARKET SIZE ESTIMATION
  • 14.2.1 BOTTOM-UP APPROACH
  • 14.2.2 TOP-DOWN APPROACH
• 14.3 FORECAST NUMBER CALCULATION
• 14.4 DATA TRIANGULATION
• 14.5 FACTOR ANALYSIS
• 14.6 ASSUMPTIONS
• 14.7 LIMITATIONS & RISKS

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS